Previous 10 | Next 10 |
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Verrica Pharmaceuticals Inc. (NasdaqGM: VRCA). In December 2020, the Company submitted a New ...
2024-02-05 10:53:46 ET More on Verrica Pharmaceuticals Verrica Pharmaceuticals Inc. (VRCA) Q3 2023 Earnings Call Transcript Verrica Pharmaceuticals stock gains on Walgreens distribution deal Verrica stock rallies 55% amid positive Phase 3 results for skin drug ...
2024-02-05 10:53:46 ET More on Verrica Pharmaceuticals Verrica Pharmaceuticals Inc. (VRCA) Q3 2023 Earnings Call Transcript Verrica Pharmaceuticals stock gains on Walgreens distribution deal Verrica stock rallies 55% amid positive Phase 3 results for skin drug ...
WEST CHESTER, Pa., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the Centers ...
2024-01-05 19:05:29 ET Summary Verrica Pharmaceuticals celebrates 5-year listing on Nasdaq after significant YoY rally and notable events, including FDA approval of VP-102 and debt financing agreement. Verrica's management is hopeful for the approval of VP-102 in Japan by end of 2...
There are approximately 3-4 million diagnoses of basal cell carcinomas in the U.S. each year, with a high unmet need for new treatment options Company reiterates lesion clearance data from Part 2 of Phase 2 expected in Q2 2024 WEST CHESTER, Pa., Jan. 05, 2024 (GLOBE NEWSWIRE) -- V...
WEST CHESTER, Pa., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it received ...
WEST CHESTER, Pa., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it is growin...
2023-12-20 08:14:03 ET Polished ( POL ) +108% . Applied UV ( AUVI ) +30% . Longeveron ( LGVN ) +31% Announces Additional Positive Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel- in the Treatment of Mild A...
2023-12-18 17:21:05 ET Gainers: Xeris Biopharma Holdings ( XERS ) +4% . Intuitive Machines ( LUNR ) +3% . Century Aluminum Company ( CENX ) +3% . Coherus BioSciences ( CHRS ) +2% . Independent Bank ( INDB ) +2% . Losers: ...
News, Short Squeeze, Breakout and More Instantly...
Verrica Pharmaceuticals Inc. Company Name:
VRCA Stock Symbol:
NASDAQ Market:
Verrica Pharmaceuticals Inc. Website:
WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ("Verrica" or "the Company") (NASDAQ:VRCA), a dermatology thera...
WEST CHESTER, Pa., May 30, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Pr...
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigatin...